Eledon Pharmaceuticals Statistics

Total Valuation

ELDN has a market cap or net worth of $236.43 million. The enterprise value is $152.31 million.

Market Cap	236.43M
Enterprise Value	152.31M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

ELDN has 59.74 million shares outstanding. The number of shares has increased by 87.05% in one year.

Current Share Class	59.74M
Shares Outstanding	59.74M
Shares Change (YoY)	+87.05%
Shares Change (QoQ)	+31.22%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	20.56%
Float	46.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.08
P/TBV Ratio	5.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.53, with a Debt / Equity ratio of 0.01.

Current Ratio	6.53
Quick Ratio	6.26
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.36% and return on invested capital (ROIC) is -41.74%.

Return on Equity (ROE)	-25.36%
Return on Assets (ROA)	-33.36%
Return on Capital (ROIC)	-41.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.06M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +203.15% in the last 52 weeks. The beta is 0.77, so ELDN's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+203.15%
50-Day Moving Average	3.34
200-Day Moving Average	2.60
Relative Strength Index (RSI)	47.09
Average Volume (20 Days)	1,012,165

Short Selling Information

The latest short interest is 960,552, so 1.61% of the outstanding shares have been sold short.

Short Interest	960,552
Short Previous Month	142,854
Short % of Shares Out	1.61%
Short % of Float	2.07%
Short Ratio (days to cover)	1.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.22M
Pretax Income	-39.85M
Net Income	-21.22M
EBITDA	n/a
EBIT	-56.22M
Earnings Per Share (EPS)	-$0.55

Full Income Statement

Balance Sheet

The company has $78.19 million in cash and $501,000 in debt, giving a net cash position of $77.69 million or $1.30 per share.

Cash & Cash Equivalents	78.19M
Total Debt	501,000
Net Cash	77.69M
Net Cash Per Share	$1.30
Equity (Book Value)	76.06M
Book Value Per Share	1.85
Working Capital	69.02M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-37.42M
Capital Expenditures	n/a
Free Cash Flow	-37.42M
FCF Per Share	-$0.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-87.05%
Shareholder Yield	-87.05%
Earnings Yield	-9.23%
FCF Yield	-16.27%

Analyst Forecast

The average price target for ELDN is $16.00, which is 304.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	304.28%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.30%

Stock Forecasts

Stock Splits

The last stock split was on October 5, 2020. It was a reverse split with a ratio of 0.0555555:1.

Last Split Date	Oct 5, 2020
Split Type	Reverse
Split Ratio	0.0555555:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a